Revenue: The sum of all revenue fields included for a company's operating activities.
AnaptysBio, Inc. (ANAB) had Revenue of $91.28M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$91.28M |
$-145.23M |
|
-- |
|
$91.28M |
|
$206.23M |
|
$-114.95M |
|
$-30.28M |
|
$-145.23M |
|
$-145.23M |
|
$-145.22M |
|
$-145.22M |
|
$-145.23M |
|
$-145.22M |
|
$-114.95M |
|
$-122.86M |
|
28.38M |
|
28.38M |
|
$-5.12 |
|
$-5.12 |
|
| Balance Sheet Financials | |
$431.88M |
|
$1.85M |
|
$51.96M |
|
$483.83M |
|
$45.43M |
|
-- |
|
$367.54M |
|
$412.97M |
|
$70.87M |
|
$70.87M |
|
$70.87M |
|
30.47M |
|
| Cash Flow Statement Financials | |
$-135.34M |
|
$95.40M |
|
$127.05M |
|
$35.97M |
|
$123.08M |
|
$87.11M |
|
$34.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-125.93% |
|
-125.93% |
|
-134.60% |
|
-159.10% |
|
-159.10% |
|
$-135.69M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
-- |
|
2.24 |
|
163.01 |
|
-204.92% |
|
-204.92% |
|
-30.02% |
|
-204.92% |
|
$2.33 |
|
$-4.78 |
|
$-4.77 |
|